$9.02 Billion is the total value of Candriam S.C.A.'s 964 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ECA | Exit | ENCANA CORP | $0 | – | -26,418 | -100.0% | -0.00% | – |
LPT | Exit | LIBERTY PPTY TRsh ben int | $0 | – | -7,769 | -100.0% | -0.01% | – |
IVZ | Exit | INVESCO LTD | $0 | – | -75,497 | -100.0% | -0.02% | – |
WTR | Exit | AQUA AMERICA INC | $0 | – | -38,759 | -100.0% | -0.02% | – |
SRCI | Exit | SRC ENERGY INC | $0 | – | -504,363 | -100.0% | -0.02% | – |
WAIR | Exit | WESCO AIRCRAFT HLDGS INC | $0 | – | -201,017 | -100.0% | -0.02% | – |
PRNB | Exit | PRINCIPIA BIOPHARMA INC | $0 | – | -51,000 | -100.0% | -0.04% | – |
WLH | Exit | LYON WILLIAM HOMEScl a new | $0 | – | -192,803 | -100.0% | -0.04% | – |
ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -702,631 | -100.0% | -0.04% | – |
CISN | Exit | CISION LTD | $0 | – | -444,262 | -100.0% | -0.05% | – |
ZAYO | Exit | ZAYO GROUP HLDGS INC | $0 | – | -130,374 | -100.0% | -0.05% | – |
ARQL | Exit | ARQULE INC | $0 | – | -224,043 | -100.0% | -0.05% | – |
BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -75,107 | -100.0% | -0.05% | – |
PEGI | Exit | PATTERN ENERGY GROUP INCcl a | $0 | – | -171,204 | -100.0% | -0.05% | – |
AYR | Exit | AIRCASTLE LTD | $0 | – | -167,946 | -100.0% | -0.06% | – |
TOO | Exit | TEEKAY OFFSHORE PARTNERS L Ppartnership un | $0 | – | -4,505,176 | -100.0% | -0.07% | – |
EQH | Exit | AXA EQUITABLE HLDGS INC | $0 | – | -297,026 | -100.0% | -0.08% | – |
DERM | Exit | DERMIRA INC | $0 | – | -570,000 | -100.0% | -0.09% | – |
INST | Exit | INSTRUCTURE INC | $0 | – | -187,301 | -100.0% | -0.10% | – |
HPE | Exit | HEWLETT PACKARD ENTERPRISE C | $0 | – | -188,477 | -100.0% | -0.12% | – |
WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -37,770 | -100.0% | -0.13% | – |
MDCO | Exit | MEDICINES CO | $0 | – | -157,106 | -100.0% | -0.14% | – |
HLT | Exit | HILTON WORLDWIDE HLDGS INC | $0 | – | -116,462 | -100.0% | -0.23% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-26
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MICROSOFT CORP | 36 | Q3 2023 | 5.9% |
GILEAD SCIENCES INC | 36 | Q3 2023 | 3.1% |
MERCK & CO INC NEW | 36 | Q3 2023 | 2.6% |
REGENERON PHARMACEUTICALS | 36 | Q3 2023 | 2.0% |
JOHNSON & JOHNSON | 36 | Q3 2023 | 2.5% |
BIOGEN INC | 36 | Q3 2023 | 2.6% |
PROCTER & GAMBLE CO | 36 | Q3 2023 | 1.9% |
VERTEX PHARMACEUTICALS INC | 36 | Q3 2023 | 2.1% |
META PLATFORMS INC | 36 | Q3 2023 | 1.6% |
VISA INC | 36 | Q3 2023 | 1.2% |
View Candriam S.C.A.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-06 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-03 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-10 |
View Candriam S.C.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.